Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Diagnostics firm reports no COVID-19 cases in pets
The results align with current understanding that COVID-19 is primarily spread from human-to-human.
Study supports recommendation against testing pets for the virus

Veterinary diagnostics company IDEXX Laboratories has announced that it has seen no positive results in pets to date of SARS-CoV-2, the coronavirus strain responsible for the COVID-19 coronavirus.

The firm tested thousands of samples from cats and dogs during validation of a new veterinary test for the COVID-19 virus. The samples used for testing and validation were obtained from samples submitted to the IDEXX Laboratories for PCR testing.

Researchers say that their results align with current understanding that COVID-19 is primarily spread from human-to-human, and support the recommendation against testing pets for the COVID-19 virus.

Jay Mazelsky, president and chief executive officer of IDEXX Laboratories, said: “Should leading health authorities determine it is clinically relevant to test pets for the COVID-19 virus, IDEXX will be ready to make the IDEXX SARS-CoV-2 (COVID-19) RealPCR™ Test available.

“Pets are important members of our family, and we want to keep them healthy and safe. We will continue to monitor COVID-19 and pet health across our global IDEXX Reference Laboratories network as this situation evolves.”

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.